James M. Woolven

A Critical Assessment of Docking Programs and Scoring Functions

Gregory L. Warren, C. Webster Andrews, Anna‐Maria Capelli et al. · Journal of Medicinal Chemistry · 2005 · 1.7K citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors

Françoise Gellibert, James M. Woolven, Marie-Hélène Fouchet et al. · Journal of Medicinal Chemistry · 2004 · 222 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery

Chun‐wa Chung, Anthony Dean, James M. Woolven et al. · Journal of Medicinal Chemistry · 2011 · 190 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials

Clive Yeates, John F. Batchelor, Edward C. Capon et al. · Journal of Medicinal Chemistry · 2008 · 138 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of 4-{4-[3-(Pyridin-2-yl)-1<i>H</i>-pyrazol-4-yl]pyridin-2-yl}-<i>N</i>-(tetrahydro-2<i>H</i>- pyran-4-yl)benzamide (GW788388):  A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor

Françoise Gellibert, Anne‐Charlotte de Gouville, James M. Woolven et al. · Journal of Medicinal Chemistry · 2006 · 103 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15